Icosapent Ethyl

Icosapent, Vascepa

NADAC/unit $0.3350

No Shortage Tier 1: 42.6% PA Req: 0.6% 11 Manufacturers 18 ANDAs

vs. brand Icosapent: Generic saves up to 97% per unit

Covered Lives

Market Intelligence

2026-03-18 Class II Recall: Zydus Pharmaceuticals (USA) Inc

2025-06-18 Class II Recall: Zydus Pharmaceuticals (USA) Inc

Generic Manufacturers

AMARIN PHARMACEUTICALS IRELAND LTDAPOTEX INCASCENT PHARMACEUTICALS INCDR REDDYS LABORATORIES INCHIKMA PHARMACEUTICALS USA INCHUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTDONESOURCE SPECIALTY PTE LTDPHARMOBEDIENT CONSULTING LLCQILU PHARMACEUTICAL CO LTDTEVA PHARMACEUTICALS USAXIAMEN LP PHARMACUETICAL CO LTDZYDUS LIFESCIENCES GLOBAL FZE

Explore in the Ecosystem

rxsaver.aiCompare prices for Icosapent Ethyl drfinder.aiFind doctors who prescribe Icosapent Ethyl rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Icosapent Ethyl

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.